Merios
Metabolic Health

Fasting Insulin Levels Chart: Normal, Optimal and High Ranges

Fasting insulin chart by age and sex. Why it's a better metabolic marker than fasting glucose, and what optimal levels look like for longevity.

OCT 12, 202610 MIN READMETABOLIC HEALTHMERIOS EDITORIAL
Contents
  1. Why fasting insulin matters more than you think
  2. Fasting insulin levels chart
  3. Important context
  4. Fasting insulin by age and sex
  5. HOMA-IR: combining insulin and glucose
  6. Why your doctor probably does not test it
  7. The metabolic progression timeline
  8. How to lower fasting insulin
  9. Exercise — the most powerful tool
  10. Dietary strategies
  11. Sleep and stress
  12. Body composition
  13. When to test fasting insulin
  14. How Merios helps
  15. Sources

Your fasting glucose is 92 mg/dL. Your doctor says it is normal. You move on with your day.

But what if the real story is hiding behind a number your doctor never ordered?

Fasting insulin is a metabolic marker that can flag trouble years before fasting glucose does: in a 24-year study of adults with normal blood sugar, high fasting insulin was the strongest predictor of later dysglycemia.1 Insulin resistance is an early warning sign for type 2 diabetes, cardiovascular disease, and metabolic syndrome.23 And most physicians do not routinely test it.4

Why fasting insulin matters more than you think

Here is the key insight: your body will fight to keep blood glucose in a narrow range. It does this by producing more insulin. So in the early stages of insulin resistance, your glucose looks fine — because your pancreas is compensating by pumping out extra insulin.5 If you do not have a fasting insulin result, the TyG index calculator estimates insulin resistance from triglycerides and glucose alone.

This is called compensatory hyperinsulinemia. Your glucose is 90 mg/dL. Everything looks great. But your insulin is 20 µIU/mL — your pancreas is working overtime to achieve that result.

Eventually, the pancreas cannot keep up. Glucose starts rising. First to 100 mg/dL, then 110 mg/dL, then 126 mg/dL (the diabetes threshold). But by that point, you have been insulin resistant for years.6

Fasting insulin catches the problem at the beginning, not the end.

Fasting insulin levels chart

Here is how to interpret your fasting insulin level:

Fasting insulin (µIU/mL)Interpretation
Below 3Very insulin sensitive — typical of lean, active individuals
3–5Optimal — the target range for metabolic health and longevity
5–8Normal — within healthy range for most adults
8–12Borderline — early insulin resistance may be developing
12–20Elevated — significant insulin resistance likely present
Above 20High — strong indicator of metabolic syndrome or pre-diabetes
Above 25Very high — almost always associated with metabolic dysfunction

Important context

These bands are a rough guide, not a clinical standard: no guideline defines an optimal fasting insulin, and insulin assays are not standardized, so the same sample can read quite differently from one lab method to another.7 Population studies have instead used percentiles — in one study of healthy adults, the top quarter started at a fasting insulin of 12 µIU/mL.8

Standard lab reference ranges will call anything from about 2.6 to 24.9 µIU/mL "normal."9 This is misleading. Lab ranges reflect the tested population, and in the United States, only about 12% of adults have optimal levels across five basic metabolic markers (according to a 2019 UNC Chapel Hill study).10 The "normal" range is skewed by a metabolically unhealthy population.

An optimal fasting insulin is not just below the upper lab limit — it is well below it.

Fasting insulin by age and sex

Fasting insulin tends to increase with age, driven by declining muscle mass, increasing visceral fat, reduced physical activity, and hormonal changes. But this increase is not inevitable — it is modifiable: in a clamp study, the drop in insulin sensitivity with age was explained by rising body fat rather than age itself.11 The ranges below are illustrative, not lab reference intervals.

Age groupTypical range (µIU/mL)Optimal target
18–303–10Below 6
30–404–12Below 7
40–505–15Below 8
50–605–18Below 8
60+5–20Below 10

Women may see minor fluctuations across the menstrual cycle, with insulin resistance highest in the luteal phase and tracking estradiol and progesterone.12 Polycystic ovary syndrome (PCOS) is one of the most common causes of elevated fasting insulin in premenopausal women: it is common and carries intrinsic insulin resistance, independent of weight.13

HOMA-IR: combining insulin and glucose

Fasting insulin is most powerful when paired with fasting glucose to calculate HOMA-IR (Homeostatic Model Assessment of Insulin Resistance):

HOMA-IR = (Fasting Glucose mg/dL × Fasting Insulin µIU/mL) ÷ 405

That is the standard approximation of the 1985 model (÷ 22.5 when glucose is in mmol/L), which defines 1.0 as normal.1415

HOMA-IRInterpretation
Below 1.0Excellent insulin sensitivity
1.0–1.5Optimal
1.5–2.0Normal but worth monitoring
2.0–2.9Early insulin resistance
3.0+Significant insulin resistance

Research thresholds for insulin resistance vary with age, sex and ethnicity: population studies have proposed cut-offs from under 2 to about 3.5, so a single "2.5" rule is a simplification.1617 Many longevity physicians prefer to see it below 1.5. You can run your two fasting numbers through the HOMA-IR calculator to get your score instantly.

Why your doctor probably does not test it

Fasting insulin is not included in the standard basic metabolic panel (BMP) or comprehensive metabolic panel (CMP).18 The current screening guidelines from the ADA (American Diabetes Association) focus on fasting glucose and HbA1c (plus the oral glucose tolerance test) — all of which detect problems at a later stage.4

The reasons fasting insulin is not standard:

  • Guidelines lag behind research — clinical guidelines take years to update, and fasting insulin's utility is still debated in traditional endocrinology
  • Cost sensitivity — adding tests increases healthcare costs, and insurers push for the minimum
  • Treatment threshold uncertainty — there is no universally agreed cut-off for fasting insulin, partly because insulin assays are not standardized (unlike HbA1c ≥ 6.5% = diabetes)7
  • Variability — insulin levels can fluctuate based on recent meals, stress, sleep, and time of day, which is why averaging repeat samples is advised for individuals15

None of these are reasons to ignore it. They are reasons the system has been slow to adopt it.

The metabolic progression timeline

Understanding the typical progression from healthy to diabetic makes the case for early testing. Timing varies from person to person — in the Whitehall II cohort, insulin sensitivity fell steeply over the 5 years before diagnosis, while fasting glucose climbed sharply only in the last 36 — so treat the years below as a rough sketch:

  1. Years 0–5: Insulin rises. Glucose stays normal. Standard tests show nothing wrong.
  2. Years 5–10: Fasting glucose creeps to 100–110 mg/dL. HbA1c reaches 5.7%. Now labeled "pre-diabetic."
  3. Years 10–15: Pancreatic beta cells begin to fail. Glucose crosses 126 mg/dL. Diabetes is diagnosed.

Fasting insulin detects the problem at stage 1. Fasting glucose detects it at stage 2. HbA1c confirms it at stage 2–3.

By the time you are diagnosed with type 2 diabetes, you may already have lost much of your beta cell function — over 80%, by one leading estimate.5 This is not a sudden event. It is a slow decline that fasting insulin could have flagged a decade earlier.1

How to lower fasting insulin

Exercise — the most powerful tool

Exercise is one of the most effective ways to improve insulin sensitivity:19

  • Resistance training builds muscle mass, and muscle is the primary tissue for insulin-driven glucose disposal.5 More muscle means more capacity to absorb glucose without needing high insulin.20
  • Aerobic exercise (especially zone 2 training at 60–70% max heart rate) improves mitochondrial function and fat oxidation.21
  • High-intensity interval training (HIIT) acutely improves GLUT4 transporter activity on muscle cells.19

Even a single session of exercise improves insulin sensitivity for up to 48 hours.22 Consistency compounds the effect.

Dietary strategies

  • Reduce refined carbohydrates and sugar — these cause the largest insulin spikes23
  • Prioritize protein and healthy fats — both raise glucose less than carbohydrate-dominant meals, though protein-rich foods still trigger a sizable insulin response23
  • Increase fiber intake — soluble (viscous) fiber slows glucose absorption; in trials in type 2 diabetes it lowered HOMA-IR24
  • Consider time-restricted eating — in a small controlled trial, an early 6-hour eating window improved insulin sensitivity in men with prediabetes, even without weight loss25
  • Limit fructose — particularly from sugary beverages, which raised liver fat production and lowered insulin sensitivity in a 10-week trial26

Sleep and stress

  • Poor sleep (under 6 hours or fragmented) increases insulin resistance within days.27 One study showed a single night of sleep restriction to 4 hours reduced insulin sensitivity by 25%.28
  • Chronic stress elevates cortisol, which directly antagonizes insulin action. Cortisol tells the liver to release glucose, requiring more insulin to compensate.29

Body composition

Visceral fat (the fat around your organs) is uniquely inflammatory and insulin-resistance-promoting.3031 Losing even 5–10% of body weight in people with excess visceral fat can markedly improve insulin sensitivity in liver, muscle and fat tissue.32

When to test fasting insulin

Consider asking your doctor for a fasting insulin test if you have:

  • A family history of type 2 diabetes
  • A waist-to-hip ratio above 0.85 (women) or 0.90 (men)
  • Elevated triglycerides or low HDL-C
  • PCOS or irregular menstrual cycles
  • Difficulty losing weight despite caloric restriction
  • Fatigue after meals or frequent sugar cravings
  • An HbA1c between 5.4–5.6% (high-normal)

Or simply if you want an earlier signal of metabolic health than fasting glucose alone.

In the US, you can order a fasting insulin test directly through services like Quest Diagnostics or LabCorp without a physician order.

How Merios helps

Upload your blood test results to Merios and we extract fasting insulin, fasting glucose, and automatically calculate your HOMA-IR. Track these values over time — before and after lifestyle changes — and see them alongside your Apple Watch data (resting heart rate, HRV, activity) for a complete metabolic picture. Metabolic health is not a single number; it is a trend.

Track your fasting insulin with Merios →


This article is for informational purposes only and does not constitute medical advice. Discuss metabolic health screening with your physician.

Sources

32 references · checked October 12, 2026

  1. Dankner R, Chetrit A, Shanik MH, et al. Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report. Diabetes Care, 2009.PMID 19435961DOI
  2. Bonora E, Kiechl S, Willeit J, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Diabetes Care, 2007.PMID 17259501DOI
  3. Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes, 1998.PMID 9753305DOI
  4. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes Care, 2025.PMID 39651986DOI
  5. Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes, 2009.PMID 19336687DOI
  6. Tabák AG, Jokela M, Akbaraly TN, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet, 2009.PMID 19515410DOI
  7. Marcovina S, Bowsher RR, Miller WG, et al. Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem, 2007.PMID 17272483DOI
  8. Ascaso JF, Pardo S, Real JT, et al. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care, 2003.PMID 14633821DOI
  9. Insulin (Test 004333) — reference interval. Labcorp, 2026.
  10. Araújo J, Cai J, Stevens J. Prevalence of Optimal Metabolic Health in American Adults: National Health and Nutrition Examination Survey 2009-2016. Metab Syndr Relat Disord, 2019.PMID 30484738DOI
  11. Karakelides H, Irving BA, Short KR, et al. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes, 2010.PMID 19833885DOI
  12. Yeung EH, Zhang C, Mumford SL, et al. Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study. J Clin Endocrinol Metab, 2010.PMID 20843950DOI
  13. Cassar S, Misso ML, Hopkins WG, et al. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod, 2016.PMID 27907900DOI
  14. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985.PMID 3899825DOI
  15. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care, 2004.PMID 15161807DOI
  16. Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord, 2013.PMID 24131857DOI
  17. Tahapary DL, Pratisthita LB, Fitri NA, et al. Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes Metab Syndr, 2022.PMID 35939943DOI
  18. Comprehensive Metabolic Panel (CMP). MedlinePlus, U.S. National Library of Medicine, 2023.
  19. Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev, 2013.PMID 23899560DOI
  20. Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab, 2011.PMID 21778224DOI
  21. Toledo FG, Menshikova EV, Ritov VB, et al. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes, 2007.PMID 17536063DOI
  22. Mikines KJ, Sonne B, Farrell PA, et al. Effect of physical exercise on sensitivity and responsiveness to insulin in humans. Am J Physiol, 1988.PMID 3126668DOI
  23. Holt SH, Miller JC, Petocz P. An insulin index of foods: the insulin demand generated by 1000-kJ portions of common foods. Am J Clin Nutr, 1997.PMID 9356547DOI
  24. Jovanovski E, Khayyat R, Zurbau A, et al. Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results From a Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care, 2019.PMID 30617143DOI
  25. Sutton EF, Beyl R, Early KS, et al. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab, 2018.PMID 29754952DOI
  26. Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest, 2009.PMID 19381015DOI
  27. Buxton OM, Pavlova M, Reid EW, et al. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes, 2010.PMID 20585000DOI
  28. Donga E, van Dijk M, van Dijk JG, et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab, 2010.PMID 20371664DOI
  29. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab, 1982.PMID 7033265DOI
  30. Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol, 2019.PMID 31301983DOI
  31. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 2006.PMID 17167471DOI
  32. Magkos F, Fraterrigo G, Yoshino J, et al. Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity. Cell Metab, 2016.PMID 26916363DOI

Frequently asked questions

  • What is a normal fasting insulin level?
    Standard lab reference ranges typically list about 2.6–24.9 µIU/mL as 'normal.' However, these ranges reflect the population average — not optimal health — and there is no universal cut-off, because insulin assays are not standardized between labs. In one study of healthy adults, the top quarter started at about 12 µIU/mL. Longevity-focused physicians target below 5 µIU/mL. A level above 10 µIU/mL, even with normal fasting glucose, may indicate early insulin resistance.
  • Why doesn't my doctor test fasting insulin?
    Fasting insulin is not part of the standard metabolic panel. Most guidelines focus on fasting glucose and HbA1c, which detect diabetes at a later stage. Fasting insulin rises years before glucose does — it is an earlier signal. Some doctors consider it unnecessary because no formal guideline mandates it, but metabolic health researchers argue it should be routine.
  • What is the difference between fasting insulin and fasting glucose?
    Fasting glucose measures the sugar in your blood at a single point in time. Fasting insulin measures how hard your pancreas is working to keep that glucose normal. You can have a fasting glucose of 90 mg/dL that looks perfect, but if your fasting insulin is 18 µIU/mL, your pancreas is overworking to maintain that number — a sign of developing insulin resistance.
  • How do I lower my fasting insulin?
    The most effective strategies are: reducing refined carbohydrates and sugar, regular exercise (both aerobic and resistance training), time-restricted eating or intermittent fasting, improving sleep quality, managing stress, and losing excess visceral fat. Resistance training is particularly effective because muscle is the primary site of insulin-driven glucose disposal.
Keep reading

More from the Journal

Metabolic Health

HOMA-IR: The Insulin Resistance Score Your Doctor Never Calculates

What HOMA-IR is, how to calculate it from a basic blood test, what the optimal ranges are, and why it catches metabolic problems years before fasting glucose.

APR 17, 20269 MIN READ
Metabolic Health

Fasting Glucose 100 or 110 mg/dL: Borderline or Prediabetic?

Fasting glucose of 100 to 125 mg/dL is prediabetes. What 100 and 110 mean, how fast each tends to progress, and how to bring the number back down.

APR 30, 20265 MIN READ
Metabolic Health

How to Lower Your A1C Naturally (and How Fast It Can Drop)

A practical, evidence-based guide to lowering HbA1c without medication: the levers that move it most, how much each is worth, and a realistic 3-month timeline.

JUN 4, 20267 MIN READ
Newsletter

Like this? Get the next one in your inbox.

Merios is live on the US App Store — plus a weekly briefing with new biomarker deep-dives and plain-English study breakdowns.

Get the app